InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Warmuth Markus. Director active across 1 company, notably Monte Rosa Therapeutics, Inc.. Aggregated, 6 reports have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €469k. History available since 7 January 2026. The latest transaction was filed on 16 July 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Warmuth Markus is an insider linked to Monte Rosa Therapeutics, Inc., where he is President & CEO. His total record includes 6 filings, and across the 6 sampled filings between 2025-01-06 and 2026-07-17, sales total 468619 EUR and the modal transaction nature is Cession.